-
公开(公告)号:CA2722620A1
公开(公告)日:2009-10-01
申请号:CA2722620
申请日:2009-03-24
Applicant: ORTHOLOGIC CORP , TEXAS A & M UNIV SYS
Inventor: CARNEY DARRELL H , OLSZEWSKA-PAZDRAK BARBARA , FOSSUM THERESA W
Abstract: An agonist of a non-proteolytically activated thrombin receptor can be used in a method for treating peripheral arterial disease. The agonist can be a thrombin peptide derivative. In some embodiments, the peripheral arterial disease is characterized by intermittent claudication. The thrombin peptide derivatives to be used in the methods can have amino acid sequences similar to a region of thrombin. Usually, the thrombin peptide derivatives are 12-23 amino acid residues in length. In some cases, the thrombin peptide derivatives are dimers, and in particular, dimers that result from formation of a disulfide bond between two cysteine residues of peptide monomers.
-
公开(公告)号:DK1559431T3
公开(公告)日:2007-07-30
申请号:DK04258191
申请日:2004-12-30
Applicant: ORTHOLOGIC CORP
Inventor: HOBSON DAVID M , CROWTHER ROGER S , CARNEY DARRELL H , TANG ANDREW PO KWAN
IPC: A61K38/48 , A61K9/06 , A61K31/198 , A61K31/473 , A61K31/4745 , A61K38/36 , A61K47/10 , A61K47/12 , A61K47/16 , A61K47/18 , A61K47/20 , A61P17/02
Abstract: Disclosed are pharmaceutical compositions comprising a thrombin peptide derivatives and a chelating agent and/or a pharmaceutically acceptable thiol-containing compound. The pharmaceutical compositions optionally further comprise an antioxidant. Also, disclosed are methods for activating the non-proteolytically activated thrombin receptor in a subject in need of such treatment. The methods comprise the step of administering an effective amount of a thrombin peptide derivative in the pharmaceutical composition described above.
-
公开(公告)号:AU2002239965B2
公开(公告)日:2007-01-04
申请号:AU2002239965
申请日:2002-01-17
Applicant: ORTHOLOGIC CORP
Inventor: CROWTHER ROGER S , YANG JINPING , STIERNBERG JANET , SIMMONS DAVID J , CARNEY DARRELL H , BERGMANN JOHN , REDIN WILLIAM R
-
公开(公告)号:HK1078263A1
公开(公告)日:2006-03-10
申请号:HK05110180
申请日:2005-11-14
Applicant: ORTHOLOGIC CORP
Inventor: CARNEY DARRELL H
IPC: A61K20060101 , A61K9/16 , A61K38/48 , A61K47/34 , A61L20060101 , A61L29/00 , A61L29/08 , A61L29/16 , A61L31/00 , A61L33/16 , A61P20060101 , A61P7/00 , A61P9/00 , A61P43/00
-
公开(公告)号:CA2551525A1
公开(公告)日:2005-07-21
申请号:CA2551525
申请日:2004-12-30
Applicant: ORTHOLOGIC CORP
Inventor: HOBSON DAVID W , CROWTHER ROGER S , CARNEY DARRELL H , TANG ANDREW PO KWAN
IPC: A61K38/48 , A61K9/06 , A61K31/198 , A61K31/473 , A61K31/4745 , A61K38/36 , A61K47/10 , A61K47/12 , A61K47/16 , A61K47/18 , A61K47/20 , A61P17/02
Abstract: Disclosed are pharmaceutical compositions comprising a thrombin peptide derivatives and a chelating agent and/or a pharmaceutically acceptable thiol~containing compound. The pharmaceutical compositions optionally furthe r comprise an antioxidant. Also, disclosed are methods for activating the non~proteolytically activated thrombin receptor in a subject in need of such treatment. The methods comprise the step of administering an effective amoun t of a thrombin peptide derivative in the pharmaceutical composition described above.
-
公开(公告)号:DE69332700T2
公开(公告)日:2003-10-16
申请号:DE69332700
申请日:1993-11-08
Applicant: ORTHOLOGIC CORP
Inventor: KAUFMAN JONATHAN J , CHIABRERA ALESSANDRO
IPC: A61M11/08 , A61B8/00 , A61B8/08 , A61B17/56 , A61H23/02 , A61J7/04 , A61M15/00 , A61M16/00 , A61N7/00 , G01N29/30 , G01N29/34
Abstract: Non-invasive therapeutic treatment and/or quantitative evaluation of bone tissue are performed in vivo, by subjecting bone to an ultrasonic acoustic signal pulse of finite duration, and involving a composite sine-wave signal consisting of plural discrete frequencies that are spaced in the ultrasonic region to approximately 2 MHz; the excitation signal is repeated substantially in the range 1 to 1000 Hz. In a quantitative evaluation, the composite sine-wave signal is supplied to one of two transducers on opposite sides of the bone, and the signal received by the other transducer is processed (a) to sequentially average the most recently received given number of successive signals to obtain an averaged per-pulse signal and (b) to produce a Fourier transform of the averaged per-pulse bone-transmitted signal. In a separate operation not involving the bone, the same transducers are subjected to the same excitation, reception and processing, wherein the transducers are exposed to a medium of known acoustic properties and path length, all to the end of producing a reference Fourier transform which is processed with the Fourier transform of the bone-transmitted signal, to yield an evaluation or measurement. In a therapeutic treatment, the transducer supplied by the composite sine-wave signal is thus supplied for a period or periods of time, and with a magnitude, as may be prescribed by the physician for a given patient.
-
公开(公告)号:DE69332700D1
公开(公告)日:2003-03-27
申请号:DE69332700
申请日:1993-11-08
Applicant: ORTHOLOGIC CORP
Inventor: KAUFMAN JONATHAN J , CHIABRERA ALESSANDRO
IPC: A61M11/08 , A61B8/00 , A61B8/08 , A61B17/56 , A61H23/02 , A61J7/04 , A61M15/00 , A61M16/00 , A61N7/00 , G01N29/30 , G01N29/34
Abstract: Non-invasive therapeutic treatment and/or quantitative evaluation of bone tissue are performed in vivo, by subjecting bone to an ultrasonic acoustic signal pulse of finite duration, and involving a composite sine-wave signal consisting of plural discrete frequencies that are spaced in the ultrasonic region to approximately 2 MHz; the excitation signal is repeated substantially in the range 1 to 1000 Hz. In a quantitative evaluation, the composite sine-wave signal is supplied to one of two transducers on opposite sides of the bone, and the signal received by the other transducer is processed (a) to sequentially average the most recently received given number of successive signals to obtain an averaged per-pulse signal and (b) to produce a Fourier transform of the averaged per-pulse bone-transmitted signal. In a separate operation not involving the bone, the same transducers are subjected to the same excitation, reception and processing, wherein the transducers are exposed to a medium of known acoustic properties and path length, all to the end of producing a reference Fourier transform which is processed with the Fourier transform of the bone-transmitted signal, to yield an evaluation or measurement. In a therapeutic treatment, the transducer supplied by the composite sine-wave signal is thus supplied for a period or periods of time, and with a magnitude, as may be prescribed by the physician for a given patient.
-
公开(公告)号:DE69610326T2
公开(公告)日:2001-02-22
申请号:DE69610326
申请日:1996-11-14
Applicant: ORTHOLOGIC CORP
Inventor: SARINGER H , CULHANE J
IPC: A61H1/02
Abstract: The present invention provides continuous passive motion (CPM) devices for joints. An ankle CPM device includes a lower leg support attached at its lower end to a semi-circular track. An actuator slides along the track and can be locked in any desired position on the track. A shaft is pivotally connected at one end thereof to the actuator and a shoe is attached at the other end thereof. When the actuator is positioned at the bottom of the track the ankle joint of the patient undergoes inversion/eversion motion. When the motor housing is rotated 90 DEG and positioned near the top of the track plantar/dorsi flexion movement is obtained. A combination of both types of joint movement are obtained for the actuator in intermediate positions. A wrist CPM device includes a brace for the forearm attached to a semi-circular track on which an actuator is mounted. A hand grip is mounted on a semi-circular bracket and a shaft extends between the actuator and a coupling slidably mounted on the semi-circular bracket. With the actuator positioned below the forearm, when the actuator pivots the shaft the wrist joint undergoes ulnar/radial deviation movement and when the motor is rotated 90 DEG and positioned at the side of the arm extension/flexion movement of the wrist joint is obtained. Positioning the actuator in intermediate positions produces wrist movement which is a combination of extension/flexion and ulnar/radial deviation of the wrist joint.
-
公开(公告)号:DE69119865T2
公开(公告)日:1996-10-02
申请号:DE69119865
申请日:1991-10-16
Applicant: ORTHOLOGIC CORP
Inventor: LAMOND DONALD R , HEINZELMAN BERT
Abstract: A medical treatment device (20) is disclosed which includes a medical treatment element (36,38) and resilient securing members (32,34) which adjust or deform to conform to the particular dimensions of that part of the patient's anatomy which is to be treated. The resilient securing members (32, 34) move or deform outwardly away from the patient (22) as the device is applied to conform to the size of the patient and ensure that the patient is centered within the treatment device. The medical treatment elements (36,38) are thus accurately positioned with respect to the patient (22). This is particularly important in treatments involving the application of magnetic fields to the patient (22). In addition, the disclosed medical device (20) is relatively comfortable and can be worn by a patient (22) for a relatively long period of time. The invention also extends to the method of applying the medical treatment device (20) to the patient (22).
-
50.
公开(公告)号:EP2282765A1
公开(公告)日:2011-02-16
申请号:EP09725708.3
申请日:2009-03-24
Applicant: Orthologic Corp. , The Texas A&M University System
Inventor: CARNEY, Darrell, H. , OLSZEWSKA-PAZDRAK, Barbara , FOSSUM, Theresa, W.
CPC classification number: A61K38/4833
Abstract: Agonists of a non-proteolytically activated thrombin receptor, and more particularly, thrombin peptide derivatives, can be used in methods to cause smooth muscle relaxation. Compositions comprising thrombin peptide derivatives can be administered to a subject with a disease or disorder that can be ameliorated by relaxation of smooth muscle. Such compositions can also be administered to a subject to facilitate medical, diagnostic or surgical procedures.
-
-
-
-
-
-
-
-
-